TY - JOUR
T1 - Arginine-specific modification of rabbit muscle phosphoglucose isomerase
T2 - Differences in the inactivation by phenylglyoxal and butanedione and in the protection by substrate analogs
AU - Pullan, Linda M.
AU - Igarashi, Peter
AU - Noltmann, Ernst A.
N1 - Funding Information:
i This is paper 30 in a series of Studies on Phos-phohexose Isomerases. The work was supported in part by USPHS Research Grant AM 07203, by Biomedical Research Development Grant RR 09070, and by an award to P. Igarashi from the University of California, Riverside, Chancellor’s Patent Fund. ‘Present address: Department of Medicine, University of California, Davis Medical Center, Sacramento, Calif. 95616.
PY - 1983/3
Y1 - 1983/3
N2 - Rabbit muscle phosphoglucose isomerase was modified with phenylglyoxal or 2,3-butanedione, the reaction with either reagent resulting in loss of enzymatic activity in a biphasic mode. At slightly alkaline pH butanedione was found to be approximately six times as effective as phenylglyoxal. The inactivation process could not be significantly reversed by removal of the modifier. Competitive inhibitors of the enzyme protected partially against loss of enzyme activity by either modification. The only kind of amino acid residue affected was arginine. However, more than one arginine residue per enzyme subunit was found to be susceptible to modification by the dicarbonyl reagents. From protection experiments it was concluded (i) that both modifiers react specifically with an arginine in the phosphoglucose isomerase active site and nonspecifically with one or more arginine residues elsewhere in the enzyme molecule, (ii) that modification at either loci causes loss of catalytic activity, and (iii) that butanedione has a higher preference for active site arginine than for arginine residues outside of the catalytic center whereas the opposite is true for phenylglyoxal.
AB - Rabbit muscle phosphoglucose isomerase was modified with phenylglyoxal or 2,3-butanedione, the reaction with either reagent resulting in loss of enzymatic activity in a biphasic mode. At slightly alkaline pH butanedione was found to be approximately six times as effective as phenylglyoxal. The inactivation process could not be significantly reversed by removal of the modifier. Competitive inhibitors of the enzyme protected partially against loss of enzyme activity by either modification. The only kind of amino acid residue affected was arginine. However, more than one arginine residue per enzyme subunit was found to be susceptible to modification by the dicarbonyl reagents. From protection experiments it was concluded (i) that both modifiers react specifically with an arginine in the phosphoglucose isomerase active site and nonspecifically with one or more arginine residues elsewhere in the enzyme molecule, (ii) that modification at either loci causes loss of catalytic activity, and (iii) that butanedione has a higher preference for active site arginine than for arginine residues outside of the catalytic center whereas the opposite is true for phenylglyoxal.
UR - http://www.scopus.com/inward/record.url?scp=0020731811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020731811&partnerID=8YFLogxK
U2 - 10.1016/0003-9861(83)90167-4
DO - 10.1016/0003-9861(83)90167-4
M3 - Article
C2 - 6838203
AN - SCOPUS:0020731811
VL - 221
SP - 489
EP - 498
JO - Archives of Biochemistry and Biophysics
JF - Archives of Biochemistry and Biophysics
SN - 0003-9861
IS - 2
ER -